For over half a century, it has been widely known that lithium is the most efficacious
treatment for bipolar disorder. Yet, despite this, its prescription has consistently declined …

Introduction Lumateperone is a novel antipsychotic medication that has recently received
approval by the United States Food and Drug Administration for treatment of major …

Manic episodes are a defining, frequent and dramatically disabling occurrence in the course
of Bipolar Disorder type I. Current pharmacotherapy of mania lists a good number of agents …

Bipolar disorder (BD) can be especially challenging to treat due to the dynamic nature of its
presentation; there is a critical need for a multimodal approach to adequately address …

Background As clinical practices with lithium salts for patients diagnosed with bipolar
disorder (BD) are poorly documented in Asia, we studied the prevalence and clinical …

The bipolar disorders are a group of severe mood disorders that together afflict about 3% of
the global population. They are characterized by the presence of both manic or hypomanic …

Since the era of antipsychotic pharmacotherapy began with the discovery of the
antipsychotic properties of chlorpromazine in 1952, many new medications for psychosis …

Bipolar disorder: The foundational role of mood stabilizers | MDedge Psychiatry Skip to main
content Home Psychiatry ALL Specialities ALL Specialities Home Home / Psychiatry CME …

Bipolar disorder (BD) is a recurrent, life-long psychiatric illness affecting nearly 2% of the
world population 1, 2 that is characterized by episodes of mania and depression …

Background: Lithium was once the drug of choice for treating bipolar disorder. It has a low
therapeutic efficacy and frequently appears in hazardous concentrations in clinical practice …